Drug Delivery Solutions Market
Market Insights on Drug Delivery Solutions covering sales outlook, demand forecast & up-to-date key trends
Drug Delivery Solutions Market By Product Type (Bottles, Vials & Ampoules, Blisters, Bags & Pouches, Prefilled Syringes & Cartridges, Sachets, Trays, Tubes, Caps & Closures, Container, Jars), Material (Plastics, Glass, Metals, Paper) & Region - Forecast 2021 - 2031
Drug Delivery Solutions Market Outlook – 2021-2031
[275 pages Report] The global drug delivery solutions market size was valued at US$ 94.3 Bn in 2021 and is projected to reach US$ 181.9 Bn by the end of 2031, exhibiting growth at 6.8% CAGR between 2021 and 2031.
Drug Delivery Solutions Market Size 2021 |
US$ 94.3 Bn |
Drug Delivery Solutions Market Size 2031 |
US$ 181.9 Bn |
Value CAGR (2021-2031) |
6.8% |
Collective Value Share: Top 3 Countries (2021E) |
33% |
Regionally, South Asia is expected to dominate the drug delivery solutions market. In 2021, the drug delivery solutions market in India grew by 10.6% year-over-year (y-o-y), amid growing demand for drug delivery solution, following the outbreak of COVID-19.
Across South Asia, total sales of drug delivery solutions are estimated to reach US$ 33.2 Bn in 2031.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
Particulars |
Details |
H1 2021 |
7.6% |
H1 2022 Projected |
7.5% |
H1 2022 Expected |
7.3% |
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 20 ↓ |
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 30 ↓ |
Future Market Insights predict a comparison and review analysis of the dynamics of the drug delivery solutions market, which is principally subjected to an array of industry factors along with a few definite influences regarding the stringent rules and regulations associated with the approval of drug delivery devices.
Some new developments that have taken place in the market include the use of anti-counterfeit and track & trace technologies to gain efficiency in the supply chain. In April 2022, Amcor plc announced to expand healthcare packaging capabilities in Europe.
The market for drug delivery solutions is expected to decline by 30 basis share points (BPS) in H1-2022 (O) against comparison with H1-2021, according to an FMI analysis. However, when comparing the H1-2022 projected and H1-2022 outlook period, a decline in BPS change by 20 BPS has been noticed.
The reason behind the drug delivery solutions market decline is due to rise in the number of drug recalls and drug failures that restrict the growth of the drug delivery solutions market. Despite these prospects, it is projected that the market will expand in the years due to the development of various new drugs for different diseases.
2015-2020 Drug Delivery Solutions Market Outlook Compared to 2021-2031 Forecast
Future Market Insights has predicted the global drug delivery solutions market to rise at 6.8% CAGR from 2021 to 2031 in comparison to the 5.1% CAGR registered during 2015 to 2020. As per the study, the drug delivery solutions market is expected to hold almost about 5.8% of the healthcare industry.
Rising popularity of biological drug medications is expected to create new tailwinds for the demand in the market. These new medications are unique in relation to small molecule formulations, as a result, demand for new formats and materials is surging.
In terms of material, the glass vial packaging format is gaining immense popularity, propelling the demand in the market. Some novel biologics have properties that delaminate glass, prompting undesirable glass chipping in formulations.
Hence, key manufacturers are developing vials that are resistant to harsh temperature and improved in heating procedure so that chipping can be alleviated. Thus, new biological drug formulations are driving the demand for new packaging formats.
Regionally, Europe pharmaceutical packaging market is witnessing a growing trend of advanced design and technological features being incorporated in packaging products.
Conventional and widely used pharmaceutical packaging solutions such as blister packs and pharmaceutical bottles are incorporated with digital technology that features advanced functionality for end-user and patients.
Preference for Disposable Packaging Fuelling Demand for Drug Delivery Solutions
Conventional pharmaceutical packaging solutions include wraps and cotton among others. Advent of thermoformable materials enabled the usage of new packaging solutions such as thermoformed trays and blister packaging.
Consequently, growing demand for good lidding materials encouraged the manufacturers of pharmaceutical packaging solutions to come up with new packaging solutions with improved film laminations, increasing the adoption of thermoplastic polymers.
As the quality of healthcare continues to improve across the globe, it is anticipated that the global pharmaceutical packaging market will benefit from the surging demand for newer drug delivery solutions.
How is Demand for Flexible Packaging Solutions Affecting Drug Delivery Solutions Companies?
Rigid packaging products, traditionally preferred in the pharmaceutical industry, are rapidly being replaced by flexible packaging products made of plastics. Growing preference for flexible packaging and particularly for high-performance applications, is expected to generate new opportunities for packaging barrier films.
Steered by its lightweight, flexible, and durable properties flexible plastics, are increasingly replacing rigid packaging made of rigid plastics and other non-plastic materials (including glass and metal).
Glass and metal materials, which are prominently used in rigid packaging, offer high barrier packaging irrespective of shelf-life requirements. Furthermore, rigid packaging formats are vulnerable to breakage and corrosion.
Hence, brands are introducing new flexible packaging solutions, which can provide longer shelf life and convenient user experience. Plastic flexible packaging products can be made in opaque as well as transparent forms depending upon the merchandising requirements of products.
Thus, flexible packaging products are made of plastics which allow product manufacturers and brands the ability to enhance product appeal through innovative packaging designs.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCountry-wise Insights
How Will Expansion of India’s Healthcare Industry Impact the Demand for Drug Delivery Solutions?
“Favorable Norms for Packaging Solution to Boost Drug Delivery Solutions Demand”
India is expected to be the largest shareholder, contributing over 41% in the South Asia drug delivery solutions market by the end of 2031. Penetration of the advance healthcare facilities and cost-effective manufacturing will create conducive environment for drug delivery solutions market in India.
According to National Health Mission, the Government of India is investing extensively to upgrade existing hospitals and develop improved healthcare infrastructure, with modern pharmaceutical packaging and facilities.
This has led to an increasing demand for safe and efficient packaging solutions for pharmaceutical products in the country. Besides this, increasing production of healthcare products by India is increasing the demand for drug delivery solutions.
As per the study, consumption of sustainable and recyclable delivery solutions has increased due to high expenditure on healthcare industry, propelling the demand in India drug delivery solutions market.
Will the Demand for Drug Delivery Solutions Increase in Japan?
“Growing Sustainability Concerns to Create Growth Opportunities for Japan Drug Delivery Solutions Market”
Future Market Insights opines, Japan is one of the key producers of drug delivery solutions in East-Asia, surpassing US$ 11.9 Bn by the end of 2031. Key players in Japan are majorly focused on developing a safe product for end users.
Also, healthcare equipment service providers from Japan are undergoing a transition towards plastic delivery solutions. As these solutions are sustainable, adoption of these solutions is increasing to reduce carbon footprint.
Subsequently, the Japan drug delivery solutions market will create an incremental opportunity of US$ 7.2 Bn between 2021 and 2031.
Category-wise Insights
Why are Bottles More Preferred as Drug Delivery Solutions?
“Bottles to Remain Highly Sought-After Packaging Format for Drug Delivery Solutions”
Bottles are widely used in healthcare sector due to the convenience in packaging. As per FMI, this segment accounted for over 40% of global market share in 2020. With increasing demand for medicines and drugs, bottles are more preferred as a safe packaging solution.
Properties such as ease in storage and handling, ease in usage is mostly affecting the use of bottles for drug delivery solutions and packaging. Due to this people are more inclined towards purchasing bottles.
As a result, the usage of bottles in drug delivery solutions will expand by 1.7x and expected to lose -490 BPS by the end of 2031.
Which is the Chief Application in Drug Delivery Solutions Market?
“Demand for Injectable Drug Delivery Solutions to Outpace the Others”
In terms of application, injectable segment will lead the application segment in global drug delivery solutions. The segment held a market share of about 36% in the year 2020, estimates FMI.
Injectable segment will continue to lead the application segment of the target market due to high demand of easy to use and disposable drug delivery solutions.
However, pulmonary and nasal segments will witness significant growth, recording incremental opportunity of US$ 16.2 Bn and US$ 12.8 Bn, respectively between 2021 and 2031.
In emerging economies, government expenditure on healthcare facilities has abruptly rose in the last decade, and the injectable segment is expected to increase by 1.9x in 2021.

A unified Market Research Subscription Platform, built for today's disparate research needs.
Competitive Landscape
Companies operating in the drug delivery solutions market are aiming at expansions and strategic partnerships with other manufacturers to expand their product manufacturing capabilities and strengthen their global footprints.
For instance,
- In November 2021, Schott AG received funding from the German Federal Ministry for the Environment (BMU) to develop climate-friendly glass production and reduce carbon emissions.
- Becton, Dickinson and Company, in November 2021, had the opening ceremony of its high-tech manufacturing facility in Zaragoza, Spain, for supporting the growth of pre-filled drug delivery systems.
- In 2021, Gerresheimer AG announced a strategic partnership with Midas Pharma for the development and marketing of its own IP autoinjector.
- In October 2021, West Pharmaceutical Services, Inc. launched a new Vialg2Bag Advanced 20 mm admixture device designed specially to maximize the benefits of point-of-care nursing.
- In August 2021, Ardagh Group S.A. announced the complete acquisition of Gores Holdings V, Inc. under a special purpose acquisition agreement with The Gores Group.
Scope Of Report
Attribute |
Details |
Forecast Period |
2021-2031 |
Historical Data Available for |
2015-2020 |
Market Analysis |
US$ Million for Value, Mn Units for Volume |
Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, MEA, Oceania |
Key Countries Covered |
US, Canada, Brazil, Germany U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Australia, GCC Countries, and South Africa |
Key Segments Covered |
Product type, Material, Application and Region |
Key Companies Profiled |
|
Report Coverage |
Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
Customization & Pricing |
Available upon Request |
Drug Delivery Solutions Market By Category
By Product Type:
- Bottles
- Packer Bottles
- Liquid Bottles
- Vials & Ampoules
- Blisters
- Bags & Pouches
- Prefilled Syringes & Cartridges
- Sachets
- Trays
- Tubes
- Caps & Closures
- Container, Jars & Others
By Material:
- Plastics
- PE
- LDPE
- HDPE
- PVC
- PP
- PS
- PET
- Others
- PE
- Glass
- Metal
- Paper
By Applications:
- Nasal
- Pulmonary
- Injectable
- Eye Care
- Dermal/ Transdermal
- Other Applications
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Middle East & Africa
- Oceania
Frequently Asked Questions
What are the key trends prevailing in the drug delivery solutions market?
Adoption of advanced technology for enhancing safety and temperature monitoring is improving the demand for drug delivery solutions.
What are the key factors driving drug delivery solutions sales?
High requirement of effective & sustainable drug delivery solutions in healthcare sector will drive the demand for the drug delivery solutions market.
What is the cumulative share of top five consumers in drug delivery solutions market?
Top five companies operating in the drug delivery solutions market are Johnson & Johnson, Roche Holding AG, Novartis AG, Merck & Co. Inc., and GSK Plc. These companies covered nearly 22% to 23% of the overall market in 2020.
At what rate will drug delivery solutions market grow in Europe?
FMI has anticipated that the Europe drug delivery solutions market will exhibit growth at a CAGR of 6.1% , surpassing US$ 19.9 Bn between 2021 and 2031.
At what rate will Japan drug delivery solutions market grow?
As per FMI, Japan drug delivery solutions market is expected to rise at 8.6 % CAGR, expanding by 2.3x between 2021 and 2031.
Table of Content
1. Executive Summary 1.1. Global Market Overview 1.2. Market Analysis 1.3. Analysis and Recommendations 1.4. Global Market Overview 1.5. Market Characteristics & Attributes 1.6. Market Statistics 1.7. Analysis and Recommendations 1.7.1. Overall Market Approach 1.7.2. Target Segment 1.7.3. Target Region 1.7.4. Differentiating Strategy 1.7.5. Expected Barriers 2. Market Overview 2.1. Market Definition 2.2. Market Taxonomy 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product Innovation / Development Trends 4. Key Success Factors 4.1. Product Adoption / Usage Analysis 4.2. Product USPs / Features 5. Global Drug Delivery Solutions Market Demand Analysis 2015-2020 and Forecast, 2021-2031 5.1. Historical Market Volume (Bn Units) Analysis, 2015-2020 5.2. Current and Future Market Volume (Bn Units) Projections, 2021-2031 5.3. Y-o-Y Growth Trend Analysis 6. Global Drug Delivery Solutions Market - Pricing Analysis 6.1. Regional Pricing Analysis, by Product 6.2. Pricing Break-up 6.3. Global Average Pricing Analysis Benchmark 7. Global Drug Delivery Solutions Market Demand (US$ Mn) Analysis 2015-2020 and Forecast, 2021-2031 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2020 7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Market Background 8.1. Global Packaging Market Overview 8.2. Global Plastic Packaging Market Overview 8.3. Global Flexible Packaging Market Overview 8.4. Global Rigid Packaging Market Outlook 8.5. Global Pharmaceutical Industry Outlook 8.6. Macro-Economic Factors & Co-relation Analysis 8.6.1. Global GDP 8.6.2. GDP Per Capita 8.6.3. Manufacturing Value Added 8.6.4. Rigid Packaging Industry 8.6.5. Packaging Industry 8.7. Forecast Factors - Relevance & Impact 8.7.1. GDP Growth 8.7.2. Segmental Revenue Growth of Key Players 8.7.3. Manufacturing Value Added Growth 8.7.4. Rigid Packaging Industry Growth 8.7.5. Packaging Industry Growth 8.8. Value Chain Analysis 8.8.1. Key Market Participants 8.8.1.1. Raw Material Suppliers 8.8.1.2. Drug Delivery Solutions/Format Manufacturers 8.8.1.3. End-users 8.8.2. Profitability Margin 8.9. Market Dynamics 8.9.1. Drivers 8.9.2. Restraints 8.9.3. Opportunity Analysis 9. Impact of COVID-19 9.1. Current Statistics and Probable Future Impact 9.2. Impact of COVID-19 on Drug Delivery Solutions Market 10. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, by Product 10.1. Introduction 10.2. Historical Market Size (US$ Bn) and Volume (Bn Units) Analysis, by Product, 2015-2020 10.3. Current and Future Market Size (US$ Bn) and Volume (Bn Units) Analysis and Forecast, by Product, 2021-2031 10.3.1. Bottles 10.3.1.1. Packer Bottles 10.3.1.2. Liquid Bottles 10.3.2. Vials & Ampoules 10.3.3. Blisters 10.3.4. Bags & Pouches 10.3.5. Prefilled Syringes & Cartridges 10.3.6. Sachets 10.3.7. Trays 10.3.8. Tubes 10.3.9. Caps & Closures 10.3.10. Container, Jars & Others 10.4. Market Attractiveness Analysis, by Product 11. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, By Material 11.1. Introduction 11.2. Historical Market Size (US$ Bn) and Volume (Bn Units) Analysis, by Material, 2015-2020 11.3. Current and Future Market Size (US$ Bn) and Volume (Bn Units) Analysis and Forecast, by Material, 2021-2031 11.3.1. Plastics 11.3.1.1. PE 11.3.1.1.1. LDPE 11.3.1.1.2. HDPE 11.3.1.2. PVC 11.3.1.3. PP 11.3.1.4. PS 11.3.1.5. PET 11.3.1.6. Others 11.3.2. Glass 11.3.3. Metals 11.3.4. Paper 11.4. Market Attractiveness Analysis, by Material 12. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, by Application 12.1. Introduction 12.2. Historical Market Size (US$ Bn) and Volume (Bn Units) Analysis, by Application, 2015-2020 12.3. Current and Future Market Size (US$ Bn) and Volume (Bn Units) Analysis and Forecast, by Application, 2021-2031 12.3.1. Nasal 12.3.2. Pulmonary 12.3.3. Injectable 12.3.4. Eye Care 12.3.5. Dermal/Transdermal 12.3.6. Other Applications 12.4. Market Attractiveness Analysis, by Application 13. Global Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031, by Region 13.1. Introduction 13.2. Historical Market Size (US$ Bn) and Volume (Bn Units) Analysis, by Region, 2015-2020 13.3. Current Market Size (US$ Bn) and Volume (Bn Units) Analysis and Forecast, by Region, 2021-2031 13.3.1. North America 13.3.2. Latin America 13.3.3. Europe 13.3.4. South Asia 13.3.5. East Asia 13.3.6. Middle East and Africa (MEA) 13.3.7. Oceania 13.4. Market Attractiveness Analysis, by Region 14. North America Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031 14.1. Introduction 14.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020 14.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031 14.3.1. By Country 14.3.1.1. U.S. 14.3.1.2. Canada 14.3.2. By Product 14.3.3. By Material 14.3.4. By Applications 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By Material 14.4.4. By Applications 14.5. Key Market Participants - Intensity Mapping 15. Latin America Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031 15.1. Introduction 15.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020 15.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031 15.3.1. By Country 15.3.1.1. Brazil 15.3.1.2. Mexico 15.3.1.3. Argentina 15.3.1.4. Rest of Latin America 15.3.2. By Product 15.3.3. By Material 15.3.4. By Applications 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By Material 15.4.4. By Applications 15.5. Key Market Participants - Intensity Mapping 16. Europe Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031 16.1. Introduction 16.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020 16.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031 16.3.1. By Country 16.3.1.1. Germany 16.3.1.2. Italy 16.3.1.3. France 16.3.1.4. U.K. 16.3.1.5. Spain 16.3.1.6. BENELUX 16.3.1.7. Nordics 16.3.1.8. Russia 16.3.1.9. Poland 16.3.1.10. Rest of Europe 16.3.2. By Product 16.3.3. By Material 16.3.4. By Applications 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By Material 16.4.4. By Applications 16.5. Key Market Participants - Intensity Mapping 17. South Asia Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031 17.1. Introduction 17.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020 17.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031 17.3.1. By Country 17.3.1.1. India 17.3.1.2. Thailand 17.3.1.3. Indonesia 17.3.1.4. Malaysia 17.3.1.5. Rest of South Asia 17.3.2. By Product 17.3.3. By Material 17.3.4. By Applications 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product 17.4.3. By Material 17.4.4. By Applications 17.5. Key Market Participants - Intensity Mapping 18. East Asia Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031 18.1. Introduction 18.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020 18.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031 18.3.1. By Country 18.3.1.1. China 18.3.1.2. Japan 18.3.1.3. South Korea 18.3.1.4. Rest of East Asia 18.3.2. By Product 18.3.3. By Material 18.3.4. By Applications 18.4. Market Attractiveness Analysis 18.4.1. By Country 18.4.2. By Product 18.4.3. By Material 18.4.4. By Applications 18.5. Key Market Participants - Intensity Mapping 18.6. 19. Oceania Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031 19.1. Introduction 19.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020 19.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031 19.3.1. By Country 19.3.1.1. Australia 19.3.1.2. New Zealand 19.3.2. By Product 19.3.3. By Material 19.3.4. By Applications 19.4. Market Attractiveness Analysis 19.4.1. By Country 19.4.2. By Product 19.4.3. By Material 19.4.4. By Applications 19.5. Key Market Participants - Intensity Mapping 20. Middle East and Africa Drug Delivery Solutions Market Analysis 2015-2020 and Forecast 2021-2031 20.1. Introduction 20.2. Historical Market Size (US$ Mn) and Volume (Mn Units) Trend Analysis, by Market Taxonomy, 2015-2020 20.3. Market Size (US$ Mn) and Volume (Mn Units) Forecast, by Market Taxonomy, 2021-2031 20.3.1. By Country 20.3.1.1. GCC Countries 20.3.1.2. Turkey 20.3.1.3. Northern Africa 20.3.1.4. South Africa 20.3.1.5. Rest of Middle East and Africa 20.3.2. By Product 20.3.3. By Material 20.3.4. By Applications 20.4. Market Attractiveness Analysis 20.4.1. By Country 20.4.2. By Product 20.4.3. By Material 20.4.4. By Applications 20.5. Key Market Participants - Intensity Mapping 21. Drug Delivery Solutions Market Country-wise Analysis and Forecast 21.1. U.S. Drug Delivery Solutions Market Analysis 2021 & 2031 21.1.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.1.1.1. By Product 21.1.1.2. By Material 21.1.1.3. By Applications 21.2. Canada Drug Delivery Solutions Market Analysis 2021 & 2031 21.2.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.2.1.1. By Product 21.2.1.2. By Material 21.2.1.3. By Applications 21.3. Brazil Drug Delivery Solutions Market Analysis 2021 & 2031 21.3.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.3.1.1. By Product 21.3.1.2. By Material 21.3.1.3. By Applications 21.4. Mexico Drug Delivery Solutions Market Analysis 2021 & 2031 21.4.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.4.1.1. By Product 21.4.1.2. By Material 21.4.1.3. By Applications 21.5. Germany Drug Delivery Solutions Market Analysis 2021 & 2031 21.5.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.5.1.1. By Product 21.5.1.2. By Material 21.5.1.3. By Applications 21.6. Italy Drug Delivery Solutions Market Analysis 2021 & 2031 21.6.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.6.1.1. By Product 21.6.1.2. By Material 21.6.1.3. By Applications 21.7. France Drug Delivery Solutions Market Analysis 2021 & 2031 21.7.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.7.1.1. By Product 21.7.1.2. By Material 21.7.1.3. By Applications 21.8. U.K. Drug Delivery Solutions Market Analysis 2021 & 2031 21.8.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.8.1.1. By Product 21.8.1.2. By Material 21.8.1.3. By Applications 21.9. Spain Drug Delivery Solutions Market Analysis 2021 & 2031 21.9.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.9.1.1. By Product 21.9.1.2. By Material 21.9.1.3. By Applications 21.10. Russia Drug Delivery Solutions Market Analysis 2021 & 2031 21.10.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.10.1.1. By Product 21.10.1.2. By Material 21.10.1.3. By Applications 21.11. GCC Countries Drug Delivery Solutions Market Analysis 2021 & 2031 21.11.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.11.1.1. By Product 21.11.1.2. By Material 21.11.1.3. By Applications 21.12. China Drug Delivery Solutions Market Analysis 2021 & 2031 21.12.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.12.1.1. By Product 21.12.1.2. By Material 21.12.1.3. By Applications 21.13. Japan Drug Delivery Solutions Market Analysis 2021 & 2031 21.13.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.13.1.1. By Product 21.13.1.2. By Material 21.14. India Drug Delivery Solutions Market Analysis 2021 & 2031 21.14.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.14.1.1. By Product 21.14.1.2. By Material 21.15. Australia Drug Delivery Solutions Market Analysis 2021 & 2031 21.15.1. Market Volume (Mn Units) and Value (US$ Mn) Analysis and Forecast, by Market Taxonomy 21.15.1.1. By Product 21.15.1.2. By Material 21.15.1.3. By Applications 22. Market Structure Analysis 22.1. Market Analysis, by Tier of Drug Delivery Solutions Companies 22.2. Market Share Analysis of Top Players 22.3. Market Presence Analysis 23. Competition Analysis 23.1. Competition Dashboard 23.2. Competition Benchmarking 23.3. Customer Deep Dive 23.3.1. Drug Manufacturers (Key Customers) 23.3.1.1. Pfizer Inc. 23.3.1.2. GlaxoSmithKline (GSK) plc. 23.3.1.3. Sanofi 23.3.1.4. Roche Holding AG 23.3.1.5. Novartis AG 23.3.1.6. Allergan (Abbvie Inc.) 23.3.1.7. Johnson & Johnson 23.3.1.8. Merck & Co., Inc. 23.3.1.9. Sun Pharmaceutical Industries Ltd. 23.3.1.10. Cadila Healthcare 23.3.2. Drug Delivery Solutions Manufacturers (Key Global Market Players) 23.3.3. Amcor Plc 23.3.3.1. Overview 23.3.3.2. Product Portfolio 23.3.3.3. Profitability by Market Segments 23.3.3.4. Sales Footprint 23.3.3.5. Strategy Overview 23.3.3.5.1. Marketing Strategy 23.3.3.5.2. Product Strategy 23.3.3.5.3. Channel Strategy 23.3.4. Schott AG 23.3.4.1. Overview 23.3.4.2. Product Portfolio 23.3.4.3. Profitability by Market Segments 23.3.4.4. Sales Footprint 23.3.4.5. Strategy Overview 23.3.4.5.1. Marketing Strategy 23.3.4.5.2. Product Strategy 23.3.4.5.3. Channel Strategy 23.3.5. Gerresheimer AG 23.3.5.1. Overview 23.3.5.2. Product Portfolio 23.3.5.3. Profitability by Market Segments 23.3.5.4. Sales Footprint 23.3.5.5. Strategy Overview 23.3.5.5.1. Marketing Strategy 23.3.5.5.2. Product Strategy 23.3.5.5.3. Channel Strategy 23.3.6. Berry Global, Inc. 23.3.6.1. Overview 23.3.6.2. Product Portfolio 23.3.6.3. Profitability by Market Segments 23.3.6.4. Sales Footprint 23.3.6.5. Strategy Overview 23.3.6.5.1. Marketing Strategy 23.3.6.5.2. Product Strategy 23.3.6.5.3. Channel Strategy 23.3.7. Klockner Pentaplast Group 23.3.7.1. Overview 23.3.7.2. Product Portfolio 23.3.7.3. Profitability by Market Segments 23.3.7.4. Sales Footprint 23.3.7.5. Strategy Overview 23.3.7.5.1. Marketing Strategy 23.3.7.5.2. Product Strategy 23.3.7.5.3. Channel Strategy 23.3.8. Becton, Dickinson and Company 23.3.8.1. Overview 23.3.8.2. Product Portfolio 23.3.8.3. Profitability by Market Segments 23.3.8.4. Sales Footprint 23.3.8.5. Strategy Overview 23.3.8.5.1. Marketing Strategy 23.3.8.5.2. Product Strategy 23.3.8.5.3. Channel Strategy 23.3.9. Ardagh Group S.A. 23.3.9.1. Overview 23.3.9.2. Product Portfolio 23.3.9.3. Profitability by Market Segments 23.3.9.4. Sales Footprint 23.3.9.5. Strategy Overview 23.3.9.5.1. Marketing Strategy 23.3.9.5.2. Product Strategy 23.3.9.5.3. Channel Strategy 23.3.10. West Pharmaceutical Service, Inc. 23.3.10.1. Overview 23.3.10.2. Product Portfolio 23.3.10.3. Profitability by Market Segments 23.3.10.4. Sales Footprint 23.3.10.5. Strategy Overview 23.3.10.5.1. Marketing Strategy 23.3.10.5.2. Product Strategy 23.3.10.5.3. Channel Strategy 23.3.11. Bilcare Limited 23.3.11.1. Overview 23.3.11.2. Product Portfolio 23.3.11.3. Profitability by Market Segments 23.3.11.4. Sales Footprint 23.3.11.5. Strategy Overview 23.3.11.5.1. Marketing Strategy 23.3.11.5.2. Product Strategy 23.3.11.5.3. Channel Strategy 23.3.12. Wipak Group 23.3.12.1. Overview 23.3.12.2. Product Portfolio 23.3.12.3. Profitability by Market Segments 23.3.12.4. Sales Footprint 23.3.12.5. Strategy Overview 23.3.12.5.1. Marketing Strategy 23.3.12.5.2. Product Strategy 23.3.12.5.3. Channel Strategy 23.3.13. Mondi Plc 23.3.13.1. Overview 23.3.13.2. Product Portfolio 23.3.13.3. Profitability by Market Segments 23.3.13.4. Sales Footprint 23.3.13.5. Strategy Overview 23.3.13.5.1. Marketing Strategy 23.3.13.5.2. Product Strategy 23.3.13.5.3. Channel Strategy 23.3.14. Sealed Air Corporation 23.3.14.1. Overview 23.3.14.2. Product Portfolio 23.3.14.3. Profitability by Market Segments 23.3.14.4. Sales Footprint 23.3.14.5. Strategy Overview 23.3.14.5.1. Marketing Strategy 23.3.14.5.2. Product Strategy 23.3.14.5.3. Channel Strategy 23.3.15. Constantia Flexibles 23.3.15.1. Overview 23.3.15.2. Product Portfolio 23.3.15.3. Profitability by Market Segments 23.3.15.4. Sales Footprint 23.3.15.5. Strategy Overview 23.3.15.5.1. Marketing Strategy 23.3.15.5.2. Product Strategy 23.3.15.5.3. Channel Strategy 23.3.16. Clondalkin Group Holdings B.V. 23.3.16.1. Overview 23.3.16.2. Product Portfolio 23.3.16.3. Profitability by Market Segments 23.3.16.4. Sales Footprint 23.3.16.5. Strategy Overview 23.3.16.5.1. Marketing Strategy 23.3.16.5.2. Product Strategy 23.3.16.5.3. Channel Strategy 23.3.17. West Rock Company 23.3.17.1. Overview 23.3.17.2. Product Portfolio 23.3.17.3. Profitability by Market Segments 23.3.17.4. Sales Footprint 23.3.17.5. Strategy Overview 23.3.17.5.1. Marketing Strategy 23.3.17.5.2. Product Strategy 23.3.17.5.3. Channel Strategy 23.3.18. UDG Healthcare plc 23.3.18.1. Overview 23.3.18.2. Product Portfolio 23.3.18.3. Profitability by Market Segments 23.3.18.4. Sales Footprint 23.3.18.5. Strategy Overview 23.3.18.5.1. Marketing Strategy 23.3.18.5.2. Product Strategy 23.3.18.5.3. Channel Strategy 23.3.19. Catalent, Inc. 23.3.19.1. Overview 23.3.19.2. Product Portfolio 23.3.19.3. Profitability by Market Segments 23.3.19.4. Sales Footprint 23.3.19.5. Strategy Overview 23.3.19.5.1. Marketing Strategy 23.3.19.5.2. Product Strategy 23.3.19.5.3. Channel Strategy 23.3.20. Sonocco Products Company 23.3.20.1. Overview 23.3.20.2. Product Portfolio 23.3.20.3. Profitability by Market Segments 23.3.20.4. Sales Footprint 23.3.20.5. Strategy Overview 23.3.20.5.1. Marketing Strategy 23.3.20.5.2. Product Strategy 23.3.20.5.3. Channel Strategy 23.3.21. Reike Corporation 23.3.21.1. Overview 23.3.21.2. Product Portfolio 23.3.21.3. Profitability by Market Segments 23.3.21.4. Sales Footprint 23.3.21.5. Strategy Overview 23.3.21.5.1. Marketing Strategy 23.3.21.5.2. Product Strategy 23.3.21.5.3. Channel Strategy 23.3.22. Adelphi Healthcare Packaging 23.3.22.1. Overview 23.3.22.2. Product Portfolio 23.3.22.3. Profitability by Market Segments 23.3.22.4. Sales Footprint 23.3.22.5. Strategy Overview 23.3.22.5.1. Marketing Strategy 23.3.22.5.2. Product Strategy 23.3.22.5.3. Channel Strategy (Asia Pacific based Key Market Players) 23.3.23. Nipro Corporation 23.3.23.1. Overview 23.3.23.2. Product Portfolio 23.3.23.3. Profitability by Market Segments 23.3.23.4. Sales Footprint 23.3.23.5. Strategy Overview 23.3.23.5.1. Marketing Strategy 23.3.23.5.2. Product Strategy 23.3.23.5.3. Channel Strategy 23.3.24. Uflex Ltd. 23.3.24.1. Overview 23.3.24.2. Product Portfolio 23.3.24.3. Profitability by Market Segments 23.3.24.4. Sales Footprint 23.3.24.5. Strategy Overview 23.3.24.5.1. Marketing Strategy 23.3.24.5.2. Product Strategy 23.3.24.5.3. Channel Strategy 23.3.25. ACG Pharmapack Pvt. Ltd. 23.3.25.1. Overview 23.3.25.2. Product Portfolio 23.3.25.3. Profitability by Market Segments 23.3.25.4. Sales Footprint 23.3.25.5. Strategy Overview 23.3.25.5.1. Marketing Strategy 23.3.25.5.2. Product Strategy 23.3.25.5.3. Channel Strategy 23.3.26. Piramal Glass Limited 23.3.26.1. Overview 23.3.26.2. Product Portfolio 23.3.26.3. Profitability by Market Segments 23.3.26.4. Sales Footprint 23.3.26.5. Strategy Overview 23.3.26.5.1. Marketing Strategy 23.3.26.5.2. Product Strategy 23.3.26.5.3. Channel Strategy 23.3.27. Parekhplast India Ltd. 23.3.27.1. Overview 23.3.27.2. Product Portfolio 23.3.27.3. Profitability by Market Segments 23.3.27.4. Sales Footprint 23.3.27.5. Strategy Overview 23.3.27.5.1. Marketing Strategy 23.3.27.5.2. Product Strategy 23.3.27.5.3. Channel Strategy 23.3.28. Shandong Pharmaceutical Glass Co., Ltd. 23.3.28.1. Overview 23.3.28.2. Product Portfolio 23.3.28.3. Profitability by Market Segments 23.3.28.4. Sales Footprint 23.3.28.5. Strategy Overview 23.3.28.5.1. Marketing Strategy 23.3.28.5.2. Product Strategy 23.3.28.5.3. Channel Strategy 23.3.29. Avesta Continental Pack 23.3.29.1. Overview 23.3.29.2. Product Portfolio 23.3.29.3. Profitability by Market Segments 23.3.29.4. Sales Footprint 23.3.29.5. Strategy Overview 23.3.29.5.1. Marketing Strategy 23.3.29.5.2. Product Strategy 23.3.29.5.3. Channel Strategy 23.3.30. Shanghai Tongpeng Electric Material Co., Ltd. 23.3.30.1. Overview 23.3.30.2. Product Portfolio 23.3.30.3. Profitability by Market Segments 23.3.30.4. Sales Footprint 23.3.30.5. Strategy Overview 23.3.30.5.1. Marketing Strategy 23.3.30.5.2. Product Strategy 23.3.30.5.3. Channel Strategy 23.3.31. Khemka Glass 23.3.31.1. Overview 23.3.31.2. Product Portfolio 23.3.31.3. Profitability by Market Segments 23.3.31.4. Sales Footprint 23.3.31.5. Strategy Overview 23.3.31.5.1. Marketing Strategy 23.3.31.5.2. Product Strategy 23.3.31.5.3. Channel Strategy 23.3.32. TPAC Packaging India Private Limited (Sunpet) 23.3.32.1. Overview 23.3.32.2. Product Portfolio 23.3.32.3. Profitability by Market Segments 23.3.32.4. Sales Footprint 23.3.32.5. Strategy Overview 23.3.32.5.1. Marketing Strategy 23.3.32.5.2. Product Strategy 23.3.32.5.3. Channel Strategy 24. Assumptions and Acronyms Used 25. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Drug Delivery Solutions Market Value (US$ Bn) Analysis, By Product, 2015H-2031F Table 02: Global Drug Delivery Solutions Market Volume (Bn Units) Analysis, By Product, 2015H-2031F Table 03: Global Drug Delivery Solutions Market Value (US$ Bn) Analysis, By Material, 2015H-2031F Table 04: Global Drug Delivery Solutions Market Volume (Bn Units) Analysis, By Material, 2015H-2031F Table 05: Global Drug Delivery Solutions Market Value (US$ Bn) Analysis, By Applications, 2015H-2031F Table 06: Global Drug Delivery Solutions Market Volume (Bn Units) Analysis, By Applications, 2015H-2031F Table 07: Global Drug Delivery Solutions Market Value (US$ Bn) Analysis, By Region, 2015H-2031F Table 08: Global Drug Delivery Solutions Market Volume (Bn Units) Analysis, By Region, 2015H-2031F Table 09: North America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F Table 10: North America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F Table 11: North America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F Table 12: North America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F Table 13: North America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F Table 14: North America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F Table 15: North America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F Table 16: North America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F Table 17: Latin America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F Table 18: Latin America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F Table 19: Latin America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F Table 20: Latin America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F Table 21: Latin America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F Table 22: Latin America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F Table 23: Latin America Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F Table 24: Latin America Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F Table 25: Europe Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F Table 26: Europe Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F Table 27: Europe Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F Table 28: Europe Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F Table 29: Europe Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F Table 30: Europe Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F Table 31: Europe Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F Table 32: Europe Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F Table 33: South Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F Table 34: South Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F Table 35: South Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F Table 36: South Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F Table 37: South Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F Table 38: South Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F Table 39: South Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F Table 40: South Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F Table 41: East Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F Table 42: East Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F Table 43: East Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F Table 44: East Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F Table 45: East Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F Table 46: East Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F Table 47: East Asia Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F Table 48: East Asia Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F Table 49: Oceania Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F Table 50: Oceania Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F Table 51: Oceania Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F Table 52: Oceania Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F Table 53: Oceania Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F Table 54: Oceania Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F Table 55: Oceania Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F Table 56: Oceania Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F Table 57: Middle East and Africa Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Product, 2015H-2031F Table 58: Middle East and Africa Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Product, 2015H-2031F Table 59: Middle East and Africa Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Material, 2015H-2031F Table 60: Middle East and Africa Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Material, 2015H-2031F Table 61: Middle East and Africa Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Applications, 2015H-2031F Table 62: Middle East and Africa Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Applications, 2015H-2031F Table 63: Middle East and Africa Drug Delivery Solutions Market Value (US$ Mn) Analysis, By Country, 2015H-2031F Table 64: Middle East and Africa Drug Delivery Solutions Market Volume (Mn Units) Analysis, By Country, 2015H-2031F
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Drug Delivery Solutions Market Share Analysis, By Product, 2021E & 2031F Figure 02: Global Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F Figure 03: Global Drug Delivery Solutions Market Y-o-Y Analysis, By Product, 2019H-2031F Figure 04: Global Drug Delivery Solutions Market Share Analysis, By Material, 2021E & 2031F Figure 05: Global Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F Figure 06: Global Drug Delivery Solutions Market Attractiveness Analysis, By Material, 2021E-2031F Figure 07: Global Drug Delivery Solutions Market Share Analysis, By Applications, 2021E & 2031F Figure 08: Global Drug Delivery Solutions Market Y-o-Y Analysis, By Applications, 2019H-2031F Figure 09: Global Drug Delivery Solutions Market Attractiveness Analysis, By Applications, 2021E-2031F Figure 10: Global Drug Delivery Solutions Market Share Analysis, By Region 2021E & 2031F Figure 11: Global Drug Delivery Solutions Market Y-o-Y Analysis, By Region, 2019H-2031F Figure 12: Global Drug Delivery Solutions Market Attractiveness Analysis, By Region, 2021E-2031F Figure 13: North America Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F Figure 14: North America Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F Figure 15: North America Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E) Figure 16: North America Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F Figure 17: Latin America Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F Figure 18: Latin America Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F Figure 19: Latin America Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E) Figure 20: Latin America Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F Figure 21: Europe Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F Figure 22: Europe Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F Figure 23: Europe Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E) Figure 24: Europe Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F Figure 25: South Asia Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F Figure 26: South Asia Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F Figure 27: South Asia Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E) Figure 28: South Asia Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F Figure 29: East Asia Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F Figure 30: East Asia Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F Figure 31: East Asia Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E) Figure 32: East Asia Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F Figure 33: Oceania Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F Figure 34: Oceania Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F Figure 35: Oceania Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E) Figure 36: Oceania Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F Figure 37: Middle East and Africa Drug Delivery Solutions Market Attractiveness Analysis, By Product, 2021E-2031F Figure 38: Middle East and Africa Drug Delivery Solutions Market Y-o-Y Analysis, By Material, 2019H-2031F Figure 39: Middle East and Africa Drug Delivery Solutions Market Value Share Analysis, By Applications, 2021(E) Figure 40: Middle East and Africa Drug Delivery Solutions Market Share Analysis, By Country, 2021E & 2031F Figure 41: U.S. Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 42: U.S. Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 43: U.S. Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 44: Canada Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 45: Canada Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 46: Canada Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 47: Brazil Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 48: Brazil Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 49: Brazil Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 50: Mexico Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 51: Mexico Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 52: Mexico Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 53: Germany Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 54: Germany Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 55: Germany Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 56: Italy Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 57: Italy Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 58: Italy Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 59: France Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 60: France Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 61: France Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 62: U.K. Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 63: U.K. Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 64: U.K. Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 65: Spain Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 66: Spain Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 67: Spain Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 68: Russia Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 69: Russia Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 70: Russia Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 71: GCC Countries Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 72: GCC Countries Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 73: GCC Countries Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 74: China Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 75: China Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 76: China Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 77: Japan Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 78: Japan Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 79: Japan Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 80: India Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 81: India Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 82: India Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F) Figure 83: Australia Drug Delivery Solutions Market Share Analysis, By Product, 2021(E) & 2031(F) Figure 84: Australia Drug Delivery Solutions Market Share Analysis, By Material, 2021(E) & 2031(F) Figure 85: Australia Drug Delivery Solutions Market Share Analysis, By Applications, 2021(E) & 2031(F)
Need specific information?
Request CustomizationExplore Packaging Insights
View Reports